Prelude Therapeutics Incorporated

Prelude Therapeutics is a drug development company working on cancer treatments targeting specific genetic mutations. The company is testing medicines designed to treat blood cancers like myelofibrosis and polycythemia vera, as well as advanced breast cancer. These drugs work by targeting particular mutations that drive cancer growth in individual patients. Prelude was founded in 2016 and collaborates with other biotech firms to develop and test its medications.